NIHR Oxford Biomedical Research Centre

Enabling translational research through partnership

MENUMENU
  • About
    • About the NIHR Oxford Biomedical Research Centre
    • A Guide to What We Do
    • Activities during COVID-19
    • Strategic Partnership Board
    • Steering Committee
    • Promoting Equality, Diversity and Inclusion in Research
    • Current Vacancies
    • Contact Us
    • Stay in Touch
  • Research
        • OUR 20 RESEARCH THEMES

        • Antimicrobial Resistance and Modernising Microbiology
        • Cardiovascular
        • Clinical Informatics and Big Data
        • Diabetes and Metabolism
        • Gastroenterology and Mucosal Immunity
        • Genomic Medicine
        • Haematology and Stem Cells
        • Imaging
        • Molecular Diagnostics
        • Multi-Modal Cancer Therapies
        • Multi-Morbidity and Long-Term Conditions
        • Musculoskeletal
        • Neurological Conditions
        • Obesity, Diet and Lifestyle
        • Partnerships for Health, Wealth and Innovation
        • Respiratory
        • Stroke and Vascular Dementia
        • Surgical Innovation and Evaluation
        • Technology and Digital Health
        • Vaccines for Emerging and Endemic Diseases
        • Oxford Biomedical Research Centre activities during COVID-19
  • Patient & Public Involvement
    • About Patient and Public Involvement
      • Our Work with Patients and the Public
      • Learn More About Our Research
      • Patient Involvement Blog
      • External Links
    • For Patients, Carers and the Public
      • Current Listings for Involvement
      • REGISTER INTEREST
      • Patient and Public Involvement Workshops
    • PPI Resources for Researchers
      • PPI Strategy
      • A Researcher’s Guide to PPI
      • PPI Resources for Researchers
      • PPI Briefing Notes
      • PPI Case Studies
      • PPI Advisory Group
      • PPI Events for Researchers
      • Post a PPI Listing
      • Public Engagement for Researchers
      • Public Engagement Case Studies
  • Training Hub
    • Training Hub
    • Fellowships
    • Funding Opportunities
    • Clinical Researchers and Scientists
    • Nurses, Midwives and Allied Health Professionals
    • Next Generation Leaders Programme
    • Useful Links
    • Training and Education Resources
    • Upcoming Training Events & Courses
  • Industry
    • Collaborate with Oxford BRC
    • What Can We Do For Your Organisation?
    • Who Do We Work With?
    • IP and Licensing
    • Contacts for Industry
  • Videos
  • News
  • Events

Other News

You are here: Home > News listings for COVID-19

News for COVID-19

Human challenge trial launches to study immune response to COVID-19

19 April 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19, Vaccines for Emerging and Endemic Diseases

Researchers at the University of Oxford have launched a human challenge trial to look at what kind of immune response can stop people from becoming re-infected. The team, led by the NIHR Oxford Biomedical Research Centre Director Professor Helen McShane (pictured right), also want to find out how the immune system reacts to a second … Read more

National study looks at long-term lung damage from COVID-19

7 April 2021 · Listed under COVID-19, Respiratory

A new national study involving researchers from Oxford will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability. Many people recovering from COVID-19 suffer from long-term symptoms of lung damage, including breathlessness, … Read more

Risk of severe COVID-19 from asthma and other respiratory diseases may be only modestly increased, new analysis suggests

1 April 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Obesity, Diet and Lifestyle, Respiratory

An analysis of 8.3 million health care records in England shows that people with asthma have only a small increased risk of developing severe Covid-19. The study, led by University of Oxford researchers, examined routine patient data collected between January and April 2020 to generate risk assessments for severe COVID-19 in people with chronic respiratory … Read more

Oxford researchers release cheap, quick COVID-19 antibody test

29 March 2021 · Listed under COVID-19, Gastroenterology and Mucosal Immunity

An international research team led by Oxford University scientists has developed a portable test for antibodies that fight the novel coronavirus that causes COVID-19. The test, which spots the presence of virus-fighting antibodies rather than a coronavirus infection, can be adapted to work on blood from a finger prick, making it quick and easy to … Read more

New study finds strong immune response following COVID-19 vaccination

26 March 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, COVID-19, Gastroenterology and Mucosal Immunity, Vaccines for Emerging and Endemic Diseases

A new study has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine, and that after two doses levels of protection were even stronger. The PITCH (Protective Immunity from T cells to COVID-19 in Health workers) study, led by Oxford and Sheffield Universities with … Read more

Seven in ten patients hospitalised with COVID-19 not fully recovered five months after discharge

24 March 2021 · Listed under Cardiovascular, COVID-19, Imaging, Respiratory

A majority of survivors who left hospital following COVID-19 had not fully recovered five months after discharge and continued to experience negative impacts on their physical and mental health, as well as their ability to work, according to results released by a major national study into the longer-term effect of the COVID-19. The PHOSP-COVID study, … Read more

Two doses of vaccine offer same protection from COVID as prior infection, study finds

15 March 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19, Vaccines for Emerging and Endemic Diseases

Two doses of either the Pfizer or Oxford-AstraZeneca vaccine offer similar protection against symptomatic SARS-CoV-2 infection to that coming from natural immunity after infection, an ongoing study of healthcare workers has found. None of the 1,456 healthcare workers at Oxford University Hospitals (OUH) NHS Foundation Trust who had received two vaccines had a symptomatic infection … Read more

Oxford study reveals public attitudes to vaccine roll-out programmes

23 February 2021 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

An international study led by University of Oxford health economists and political scientists has found that there is much greater consistency in public attitudes across a number of countries about who should be prioritised for COVID-19 vaccination than there is in national policies. The study, published on the medRxiv pre-print server, could have important implications … Read more

Oxford study shows high level of readmissions and death after COVID-19 discharge

22 February 2021 · Listed under Clinical Informatics and Big Data, COVID-19

Some 30% of patients discharged after being admitted to hospital with community-acquired COVID-19 had been readmitted or died within 60 days, a study by Oxford researchers has shown. In a paper published in the European Journal of Public Health, they found that, as anticipated, rates of readmission or death were higher among older adults. However, … Read more

Oxford-led technology to help those at high risk from Covid-19

16 February 2021 · Listed under Clinical Informatics and Big Data, COVID-19, Multimorbidity and Long-Term Conditions

More people in England at high risk from Covid-19 will get priority access to vaccines thanks to new technology developed by a University of Oxford-led team of researchers that can identify those who may be most vulnerable to the virus. Research led by Professor Julia Hippisley-Cox in the University of Oxford’s Nuffield Department of Primary … Read more

Oxford University extends COVID-19 vaccine study to children

15 February 2021 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

The University of Oxford coronavirus vaccine team has launched the first study to assess the safety and immune responses in children and young adults of their ChAdOx1 nCoV-19 vaccine. The study, which will be conducted with partner sites in London, Southampton and Bristol, builds on previous trials of the vaccine, which have shown that it … Read more

Tocilizumab found to reduce deaths in hospitalised COVID-19patients

11 February 2021 · Listed under Clinical Informatics and Big Data, COVID-19

The RECOVERY Trial, the world’s largest randomised trial of potential COVID-19 treatments, has found that the anti-inflammatory drug, tocilizumab, reduces the risk of death when given to hospitalised patients with severe COVID-19. The trial, which received core funding from the NIHR Oxford Biomedical Research Centre (BRC), also showed that tocilizumab shortens the time until patients … Read more

Lateral flow devices found to be useful in screening OUH staff for coronavirus

11 February 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

Infection prevention and control clinicians and researchers at Oxford University Hospitals (OUH) have been outlining the OUH’s experience of deploying self-administered home-based lateral flow testing of its staff. In a letter published in the Journal of Infection, they said that 46,503 home-based SARS-CoV-2 lateral flow tests had been performed by asymptomatic OUH hospital staff. Of … Read more

Drug trial that could improve respiratory recovery from COVID-19 under way

10 February 2021 · Listed under COVID-19, Respiratory

A clinical trial has begun to test whether the drug Almitrine can help people who are seriously ill with COVID-19 recover from the disease. Oxford University Hospitals NHS Foundation Trust is one of three centres taking part in the trial. Patients suffering from COVID-19 pneumonia often develop very low levels of oxygen, called hypoxia, in … Read more

Common asthma treatment reduces need for hospitalisation in COVID-19 patients, study suggests

8 February 2021 · Listed under COVID-19, Respiratory

Early treatment with a medication commonly used to treat asthma appears to significantly reduce the need for urgent care and hospitalisation in people with COVID-19, researchers at the University of Oxford have found. The STOIC study found that inhaled budesonide given to patients with COVID-19 within seven days of the onset of symptoms also reduced … Read more

Oxford coronavirus vaccine shows sustained protection between doses

2 February 2021 · Listed under COVID-19, Vaccines for Emerging and Endemic Diseases

Researchers at the University of Oxford have revealed that the efficacy of the Oxford/AstraZeneca coronavirus vaccine is higher at longer prime-boost intervals, and that a single dose of the vaccine is 76% effective from 22 to up to 90 days post-vaccination. In their findings, published in Preprints with The Lancet, they report on an analysis … Read more

Fewer colorectal cancer diagnoses reported during COVID-19

29 January 2021 · Listed under Clinical Informatics and Big Data, COVID-19

University of Oxford researchers from the UK Colorectal Cancer Intelligence Hub have been investigating how the diagnosis and treatment of colorectal cancer patients has been affected by the COVID-19 pandemic. The NIHR Oxford BRC-supported researchers at the Nuffield Department of Population Health carried out the analysis with NHS Digital and experts from other UK universities … Read more

Lateral flow devices detect most infectious COVID-19 cases, study shows

22 January 2021 · Listed under Antimicrobial Resistance and Modernising Microbiology, Clinical Informatics and Big Data, COVID-19

Researchers from the University of Oxford, working with Public Health England, have used NHS Test and Trace data to find out why some individuals pass COVID-19 on to their contacts more easily than others, and if lateral flow tests are sufficient in detecting those who are most infectious.  Using information from over a quarter of … Read more

COVID-19 ‘matching service’ increased public involvement in research, HRA finds

20 January 2021 · Listed under COVID-19, Partnerships for Health, Wealth and Innovation

The Health Research Authority (HRA) has found that levels of public involvement in COVID-19 research increased following the introduction of a public involvement matching service, in a report published last week. A group of public contributors from the NIHR Oxford Biomedical Research Centre took part in the matching service and two of the contributors have … Read more

Oxford study confirms medium-term impact of COVID-19

11 January 2021 · Listed under COVID-19, Imaging

A study looking at the longer-term impact of COVID-19 has found that a significant proportion of COVID-19 patients discharged from hospital reported symptoms of breathlessness, fatigue and depression and had limited exercise capacity several weeks after leaving hospital. The University of Oxford scientists carrying out the C-MORE study found that at two to three month … Read more

  • 1
  • 2
  • 3
  • 4
  • Next Page »

News

News

  • NIHR Advance Fellowship awarded 19 April 2021
  • Human challenge trial launches to study immune response to COVID-19 19 April 2021
  • What Matters Most: A workshop methodology to hear patients’ priorities 16 April 2021
See full news archive

News Categories

Month Archives

Subscribe to the Oxford BRC Newsletter

Keep informed about the work of the Oxford BRC by subscribing to our Mailchimp e-newsletter. It is produced bimonthly and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Oxford BRC on Social Media

  • Facebook
  • Twitter
  • YouTube

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

  • Sitemap
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2021 NIHR Oxford Biomedical Research Centre

Cookies

This site uses cookies See our data control and privacy page